ExploraGenome is a whole-genome / whole-exome sequencing, analysis, and storage service launched by Italy-based Innovagenome S.r.l. Users complete the test with a saliva sample; the lab performs sequencing using NGS methods, then generates reports through bioinformatics software and AI-based solutions. Rather than a traditional enterprise SaaS product, it is positioned as a personal genome digitization and health interpretation service.
Based on the available content, ExploraGenome’s core value proposition is “test once, use long term.” Its reports cover 12 categories, including disease-related genes, diagnostic support, complex disease risk, hereditary cancer risk, carrier status, pharmacogenomics, allergies and intolerances, nutrition and diet, sports and fitness, skin and anti-aging, personality and abilities, and ancestry. Its AI modules include IntelligenomeScan, AI Diagnosis, and YourGenome&You, which are used to screen for pathogenic or likely pathogenic variants and to identify possible genetic causes in combination with symptoms or medical history.
The site shows versions such as ExploraGenome Exome, ExploraGenome Genome, and TotalGenome Array, with online purchasing supported. The service claims to include the sampling kit, shipping, testing, a complete report, and raw data with no hidden fees, but specific prices are not disclosed. The process is relatively clear: place an order and receive the kit, collect saliva, register and arrange sample pickup, undergo laboratory sequencing, complete health information, receive the report, store the digital DNA, and request future updates or on-demand analysis when needed.
Data can be stored in a cloud-based “secure space” or on physical media, which is suitable for long-term reanalysis. However, the text does not provide details on encryption, access controls, audit logs, GDPR, or medical data compliance certifications. There is also no visible evidence of API access, developer documentation, team collaboration features, role-based permissions, or integrations with third-party systems, so it should not be evaluated as an enterprise-grade SaaS platform.
Its strengths include broad report coverage, inclusion of raw data, and support for future reuse of genome data. Pharmacogenomics and carrier screening can also offer practical reference value. The drawbacks are insufficient transparency around pricing, compliance, and data governance; medical conclusions require interpretation by a physician; and the clinical value of some wellness or personality-related reports should be viewed cautiously. It is best suited for individuals who want a systematic understanding of their genetic information, couples planning pregnancy who care about carrier risks, or users who want to preserve whole-genome data for future analysis.
Access from China, logistics, payment options, and cross-border sample shipping are not explained in the text, so their status is unknown. Scalapay appears on the page, but this does not mean commonly used Chinese payment methods are supported. Chinese users interested in medical applications should prioritize locally compliant medical institutions or testing services with genetic counseling capabilities.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on exploragenome.com official site.
exploragenome.com is an Italy SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach exploragenome.com directly.